April 25, 2017 5:23 PM ET

Life Sciences Tools and Services

Company Overview of Halo Pharma, Inc.

Company Overview

Halo Pharma, Inc. provides pharmaceutical contract development and manufacturing services. It specializes in the development and commercialization of controlled substances, including drug products used for pain management and ADHD. The company has particular expertise in abuse deterrent technologies and complex IR/ER products. It offers commercial manufacturing services in various dosage forms and drug delivery platforms, including complex formulations, such as modified release tablets, capsules, topicals (sterile and non sterile), and oral solutions. The company manufactures phase I-III clinical supplies in various dosage forms; provides scientific, product development, commercial, and clin...

30 North Jefferson Road

Whippany, NJ 07981

United States

Founded in 2006





Key Executives for Halo Pharma, Inc.

Chief Executive Officer
Chief Financial Officer
Vice President of Manufacturing
Vice President of Finance
Age: 55
Vice President of Product Development
Age: 65
Compensation as of Fiscal Year 2016.

Halo Pharma, Inc. Key Developments

Egalet Corporation, Egalet Ltd. and Egalet US Inc. Enters into Drug Product Manufacturing Services Agreement with Halo Pharmaceutical, Inc

On February 28, 2017, Egalet Corporation and its wholly-owned subsidiaries, Egalet Ltd. and Egalet US Inc., entered into a Drug Product Manufacturing Services Agreement with Halo Pharmaceutical Inc. pursuant to which Egalet engaged Halo to provide certain services related to the manufacture and supply of ARYMOTM ER tablets for the company's commercial use in the United States. Egalet is obligated to purchase all of its requirements for the product from Halo through 2019, and 75% of its requirements thereafter, subject to certain limited exceptions. Egalet will purchase the product pursuant to binding purchase orders at a fixed price based on dosage strength, with specified percentage rebates for annual volumes of products ordered over a specified amount. In addition, Egalet has agreed to purchase certain minimum amounts of manufacturing and additional services per calendar quarter from Halo over the term of the agreement. If Egalet fails to meet the Quarterly Minimum, it will be required to pay to Halo the resulting shortfall. The term of the agreement is five years from the date of Egalet's first firm order for Product. The agreement will automatically extend for successive two-year renewal terms unless either party gives six months prior written notice of its intention to terminate the agreement. The agreement also contains customary representations, warranties and covenants, including with respect to the ownership of any intellectual property created pursuant to the agreement, as well as provisions relating to ordering, payment and shipping terms, regulatory matters, reporting obligations, indemnity, confidentiality and other matters.

Halo Pharmaceutical Inc. Announces Management Appointments

Halo Pharmaceutical Inc. announced the appointments of Lee Karras as its Chief Executive Officer and Barry Lederman as its Chief Financial Officer. Lee Karras is an established pharmaceutical business executive with over twenty five years of healthcare industry related experience. Prior to joining the company, Lee held executive leadership roles in several businesses. Most recently he was President of IBA Molecular North America. Barry Lederman has extensive financial and international pharmaceutical experience, having led teams of several public and private companies with global operations. Prior to joining the company, he served as the Vice President and CFO for Eisai Inc.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Halo Pharma, Inc., please visit www.halopharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.